Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis

Kamata K, Okubo M, Uchiyama T, Masaki Y, Kobayashi Y, Tanaka T (1984) Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice. Clin Immunol Immunopathol 33:31–38

Sonda K, Takahashi K, Tanabe K, Fuchinoue S, Hayasaka Y, Kawaguchi H, Teraoka S, Toma H, Ota K (1996) Clinical pharmacokinetic study of mizoribine in renal transplantation patients. Transplant Proc 28:3643–3648

Yokota S (2002) Mizoribine: mode of action and effects in clinical use. Pediatr Int 44:196–198

Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T (1997) Mizoribine in steroid-dependent nephrotic syndrome of childhood. Pediatr Nephrol 11:625–627

Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, Tanizawa T, Wada H, Maki S (2000) A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 58:317–324

Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H (2004) Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 24:147–153

Hirayama K, Kobayashi M, Hashimoto Y, Usui J, Shimizu Y, Hirayama A, Yoh K, Yamagata K, Nagase S, Nagata M, Koyama A (2004) Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. Am J Kidney Dis 44:57–63

Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S (2004) Mizoribine for the treatment of lupus nephritis in children and adolescents. Clin Nephrol 62:412–417

Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H (2005) Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis. Clin Nephrol 64:28–34

Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX, Ji YL, Lau CS, Wong AKM, Tong MKL, Chan KW, Lai KN (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343:1156–1162

Mok CC, Lai KN (2002) Mycophenolate mofetil in lupus glomerulonephritis. Am J Kidney Dis 40:447–557

Yumura W, Uchida K, Kawashima A, Kobayashi H, Miwa N, Honda K, Nitta K, Nihei H (1999) Evaluation of plasma concentration of mizoribine as an immunosuppressive agent in lupus nephritis patients (in Japanese). Jin to toseki (Kidney and Dial, Tokyo) 47:705–708

Tanaka H, Suzuki K, Nakahata T, Sato T, Ito E (2003) Mizoribine oral pulse therapy for a patient with severe lupus nephritis. Pediatr Int 45:488–490

Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Ito E, Waga S (2003) Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis. Clin Nephrol 60:390–394

Tanaka H, Nakahata T, Tsugawa K, Tsuruga K, Yumura W, Ito E (2004) Mizoribine pulse therapy for patients with flares of lupus nephritis: a one-year observation. Clin Nephrol 62:165–166

Tanaka H, Tsugawa K, Nakahata T, Kudo M, Suzuki K, Ito E (2005) Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis. Clin Nephrol 63:417–422

Tanaka H, Tateyama T, Waga S (2001) Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis. Pediatr Nephrol 16:817–819

Austin HA, Balow JE (1999) Natural history and treatment of lupus nephritis. Semin Nephrol 19:2–11

Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158–166

Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children. A review of 167 patients. Pediatrics 94:335–340

Abe Y, Tsuji Y, Hisano M, Nakada M, Miura K, Watanabe S, Odajima Y, Iikura Y (2004) Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis. Pediatr Int 46:597–600

Shibasaki T, Matsuyama H, Gomi H, Usui M, Ishimoto F, Sakai O (1996) Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. Am J Nephrol 16:167–172

Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E (2005) Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome. Tohoku J Exp Med 205:87–91

Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H (2005) Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:96–98

Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274:87–92